Korian is an actor on the temporary and permanent dependency care market in France, Germany and Italy. Co. offers and develops services related to dependency through its retirement homes (116 as of Dec 31 2009), follow-up care and rehabilitation facilities (35 as of Dec 31 2009) and psychiatric clinics (11 as of Dec 31 2009). Co.'s operations can be divided into four geographical segments: Medical and Social activity in France (retirement homes); Sanitary activity in France (follow-up care, rehabilitation, psychiatry and home medical care); Italy; and Germany.
  • TickerKORI
  • ISINFR0010386334
  • ExchangeEuronext Paris
  • SectorHealth Care Equipment & Services
  • CountryFrance

Analysts

Matthieu DRIOL

Analyse court terme - KORIAN : La tendance de fond est clairement orientée à la hausse.

La tendance de fond est clairement orientée à la hausse. Les cours progressent toujours. Les objectifs suivants sont à 34,74 € et 35,50 €. La tendance serait invalidée sous le support à 27,30 €.

Matthieu DRIOL

Short term view - KORIAN : The background trend is clearly bullish.

The background trend is clearly bullish. Prices are still making progress. The following targets are at €34.74 and €35.50. The trend would be invalidated below the support at €27.30.

Matthieu DRIOL

Short term view - KORIAN : Prices are still making progress.

The background trend is clearly bullish. Prices are still making progress. The following targets are at €34.74 and €35.50. The trend would be invalidated below the support at €27.30.

Matthieu DRIOL

Analyse court terme - KORIAN : Les cours progressent toujours.

La tendance de fond est clairement orientée à la hausse. Les cours progressent toujours. Les objectifs suivants sont à 34,74 € et 35,50 €. La tendance serait invalidée sous le support à 27,30 €.

Matthieu DRIOL

Medium term view - KORIAN : Prices are still making progress.

The background trend is clearly bullish. Prices are still making progress. The following targets are at €37.00 and €41.61. The trend would be invalidated below the support at €27.64.

Bruno de La Rochebrochard

Korian: Q2 revenue: further improvement in organic growth continues with dynamic bolt-on acquisitions

Brief Comment - Korian: (BUY, Fair Value EUR33 (+12%)) Q2 revenue: further improvement in organic growth continues with dynamic bolt-on acquisitions

Tony Lebon

Korian : Potential takeover bid on Korian: implications for ODIRNANE bond holders

Tony Lebon

Korian : Potential takeover bid on Korian: implications for ODIRNANE bond holders

Antoine Boivin-Champeaux ...
  • Baptiste Lebacq
  • Benoit Valleaux
  • Charles Lepetitpas
  • Christophe Chaput
  • Christophe-Raphaël Ganet
  • Emmanuel Matot
  • Fatma Agnès Hamdani
  • Fehmi Ben Naamane
  • Harold De Decker
  • Hela Zarrouk
  • Jean-François Granjon
  • Jeremy Garnier
  • Laurence Hofmann
  • Matthias Desmarais
  • Nicolas David
  • Oussema Denguir
  • Pierre Corby
  • Roland Pfaender
  • Salma Bouraoui
  • Yan Derocles

ODDO BHF Small & MIDCAP MORNING NEWS - 10/25/2018

...

Christophe-Raphaël Ganet

Korian : Q3 2018 revenue in line with estimates and guidance – Unambiguous confirmation of the improvement in the group’s growth path

>Q3: +6.1% and +3% lfl - At € 840m (+6.1%), Q3 revenue implies organic growth of 3%.Korian’s stock of beds increased by roughly 2,000 units over the period, mainly in Belgium, with the consolidation of the third portfolio of facilities acquired from Senior Assis.Nine-month revenue was up 6%, of which 2.9% organic. The stock of beds has increased by over 3,100 units since the beginning of the year.A fresh milestone solidifying the recovery trend ...

Antoine Boivin-Champeaux ...
  • Baptiste Lebacq
  • Benoit Valleaux
  • Charles Lepetitpas
  • Christophe Chaput
  • Christophe-Raphaël Ganet
  • Emmanuel Matot
  • Fatma Agnès Hamdani
  • Fehmi Ben Naamane
  • Harold De Decker
  • Hela Zarrouk
  • Jean-François Granjon
  • Jeremy Garnier
  • Laurence Hofmann
  • Matthias Desmarais
  • Nicolas David
  • Oussema Denguir
  • Pierre Corby
  • Roland Pfaender
  • Salma Bouraoui
  • Yan Derocles

ODDO BHF Small & MIDCAP MORNING NEWS - 25/10/2018

...

Christophe-Raphaël Ganet

Korian : CA T3 2018 en ligne et en phase avec la guidance – Confirmation explicite de la trajectoire d’amélioration de la croissance du groupe

>T3: +6.1% et +3% lfl. - A 840 M€ (+6,1%), le CA T3 fait ressortir une croissance organique de 3%.Le parc de lits exploités par Korian s’est accru d’environ 2 000 unités sur la période, principalement en Belgique avec l’intégration du 3e portefeuille d’établissements acquis auprès de Senior Assis.Aux 9 mois, le CA progresse de 6%, dont 2.9% en organique. Le parc de lits s’est accru de plus de 3 100 unités depuis le début de l’année.Un jalon supp...

Christophe-Raphaël Ganet

ODDO : Q3 2018 previews: expensive healthcare

>T3: +9.7%e forecast - After growth of around +10% in H1, our forecasts are for growth in the region of 9.7% in Q3.Growth levels are fairly disparate but we can say that the most robust growth levels will likely come from Ipsen, Sartorius Stedim Biotech and bioMérieux. The weakest growth levels will probably be generated by Guerbet, Boiron and Vétoquinol.Virbac has already reported its Q3 results, these were towards the upper end of the forecast range. Q3 pu...

1 director bought

A director at Korian Promesses bought 4,821 shares at 29.261EUR and the significance rating of the trade was 65/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing Close periods where trading activity is restricted under listing rules. The names...

Alex Koagne ...
  • Christophe Chaput
  • Christophe-Raphaël Ganet
  • Jean Sassus
  • Olfa Taamallah
  • Yan Derocles

ODDO BHF Small & MIDCAP MORNING NEWS - 10/15/2018

...

Ahmed Ben Salem ...
  • Bruno Cavalier
  • Christophe-Raphaël Ganet
  • Emira Sagaama
  • Jean Sassus
  • Laure Billoret
  • Matthias Desmarais
  • Steven Gould
  • Valentin Pernet
  • Yassine Batini

ODDO BHF SECURITIES MORNING NEWS – DETAILED COMMENTS 10/15/2018

...

Ahmed Ben Salem ...
  • Bruno Cavalier
  • Christophe-Raphaël Ganet
  • Emira Sagaama
  • Jean Sassus
  • Laure Billoret
  • Matthias Desmarais
  • Steven Gould
  • Valentin Pernet
  • Yassine Batini

ODDO BHF SECURITIES MORNING NEWS – COMMENTAIRES DETAILLES 15/10/2018

...

Alex Koagne ...
  • Christophe Chaput
  • Christophe-Raphaël Ganet
  • Jean Sassus
  • Olfa Taamallah
  • Yan Derocles

ODDO BHF Small & MIDCAP MORNING NEWS - 15/10/2018

...

Christophe-Raphaël Ganet ...
  • Michael Foundoukidis
  • Sylvain Goyon, CFA
  • Thomas Zlowodzki

ODDO BHF SECURITIES MORNING NEWS – DETAILED COMMENTS 08/28/2018

The ongoing monetary normalisation by the Fed and the imminent prospect of a similar move by the ECB, amid question marks over the real cyclical position on either side of the Atlantic, will likely put rate trends at the top of investors’ list of concerns. We have thus sought to determine the European sectors and stocks with the most exposure to this theme going forward, using weekly 6-month correlations. For a rate increase, the analysis gives a long position on banks, insurance, oil...

KORIAN SA is slightly downgraded to Slightly Positive due to an increasingly adverse environment

The independent financial analyst theScreener just slightly lowered the general evaluation of KORIAN SA (FR), active in the Health Care Providers industry. As regards its fundamental valuation, the title confirms its rating of 4 out of 4 stars while its market behaviour remains unchanged and can be qualified as defensive. However, a marginally less favourable environment forces theScreener to downgrade slightly the title, which now shows an overall rating of Slightly Positive. As of the analysis date September 25, 2018, the closing price was EUR 31.64 and its potential was estimated at EUR 33....

Ford Equity International Rating and Forecast Report

Ford Equity International Research Reports cover 60 countries with over 30,000 stocks traded on international exchanges. A proprietary quantitative system compares each company to its peers on proven measures of business value, growth characteristics, and investor behavior. Ford's three recommendation ratings buy, hold and sell, represent each stock’s return potential relative to its own country market.. The rating reports which are generated each week, include the fundamental details behind each recommendation and reflect the fundamental and price data as of the last trading day of the week...

Jehanne Leroy

Proxy Report - 14/06/2018

La politique de rémunération de Mme Boissard souffre toujours d’une faiblesse significative : la rémunération actionnariale soit basée sur des conditions de performance qui ne sont pas mesurées sur le long-terme (3 ans minimum). Cependant, la société a mis en place pour la politique de rémunération 2018 2 améliorations significatives concernant le plafonnement de la rémunération long-terme et celui des rémunérations exceptionnelles. Aussi la politique de rémunération 2018 semble préférable à celle mise en place pour 2017 et nous soutenons donc la nouvelle politique (résolution 7). Cependant, ...

SRI Quantitative KPIs

Les analyses Gaïa sont des analyses ESG (Environnement, Social, Gouvernance) dediees aux entreprises de tailles intermediaires (PME, ETI) françaises. Elles presentent 120 indicateurs quantitatifs sur les trois derniers exercices.

Matthieu DRIOL

Analyse court terme - KORIAN : La tendance de fond est clairement orientée à la hausse.

La tendance de fond est clairement orientée à la hausse. Les cours progressent toujours. Les objectifs suivants sont à 34,74 € et 35,50 €. La tendance serait invalidée sous le support à 27,30 €.

Matthieu DRIOL

Short term view - KORIAN : The background trend is clearly bullish.

The background trend is clearly bullish. Prices are still making progress. The following targets are at €34.74 and €35.50. The trend would be invalidated below the support at €27.30.

Matthieu DRIOL

Short term view - KORIAN : Prices are still making progress.

The background trend is clearly bullish. Prices are still making progress. The following targets are at €34.74 and €35.50. The trend would be invalidated below the support at €27.30.

Matthieu DRIOL

Analyse court terme - KORIAN : Les cours progressent toujours.

La tendance de fond est clairement orientée à la hausse. Les cours progressent toujours. Les objectifs suivants sont à 34,74 € et 35,50 €. La tendance serait invalidée sous le support à 27,30 €.

Matthieu DRIOL

Medium term view - KORIAN : Prices are still making progress.

The background trend is clearly bullish. Prices are still making progress. The following targets are at €37.00 and €41.61. The trend would be invalidated below the support at €27.64.

ResearchPool Subscriptions

Get the most out of your insights

Get in touch